DMAC · DiaMedica Therapeutics Inc. · Investor Relations
$8.50
+0.08 (+0.95%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$461.60M
Shares
53.93M
Volume · Oct 5
231.38K
Avg daily vol (3M)
182.57K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-10-23 12:00 UTC | DiaMedica Therapeutics Virtual KOL Event | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Second Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference Fireside Chat | Conference |
| 2026-05-07 | First Quarter 2026 Financial Results Conference Call | Earnings call |
| 2026-03-31 | Fourth Quarter 2025 Financial Results Conference Call | Earnings call |
| 2026-01-21 | Cantor KOL Webinar Highlights DM199 For PreEclampsia Looks Like A Real Drug | Event |
| 2025-09-05 | Cantor Global Healthcare Conference Fireside Chat | Conference |
| 2025-07-17 | DiaMedica's Discussion of Preeclampsia Study Part 1a Interim Results | Results publication |
| 2025-07-17 | Interim Phase 2 (Part 1a) Preeclampsia Data | Event |
| 2024-07-11 | White Paper: The Potential of DM199 to Treat Preeclampsia | Event |